Total Payments
$123,681
2024 Payments
$412.13
Companies
19
Transactions
259
Medicare Patients
11,667
Medicare Billing
$972,900
Payment Breakdown by Category
Other$97,440 (78.8%)
Consulting$12,320 (10.0%)
Food & Beverage$7,252 (5.9%)
Travel$6,669 (5.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $97,440 | 37 | 78.8% |
| Consulting Fee | $12,320 | 10 | 10.0% |
| Food and Beverage | $7,252 | 201 | 5.9% |
| Travel and Lodging | $6,669 | 11 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $109,256 | 136 | $0 (2024) |
| Abbott Laboratories | $12,740 | 50 | $0 (2023) |
| Boston Scientific Corporation | $493.70 | 14 | $0 (2024) |
| PFIZER INC. | $263.88 | 13 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $198.67 | 11 | $0 (2017) |
| Medtronic Vascular, Inc. | $116.44 | 7 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $115.18 | 9 | $0 (2024) |
| HeartFlow, Inc. | $93.82 | 1 | $0 (2023) |
| Medtronic, Inc. | $73.80 | 2 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $70.63 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $412.13 | 11 | Boston Scientific Corporation ($298.02) |
| 2023 | $821.11 | 16 | Janssen Pharmaceuticals, Inc ($517.76) |
| 2022 | $488.29 | 10 | Janssen Pharmaceuticals, Inc ($367.63) |
| 2021 | $962.76 | 8 | Janssen Pharmaceuticals, Inc ($884.22) |
| 2020 | $1,424 | 9 | Janssen Pharmaceuticals, Inc ($1,300) |
| 2019 | $15,901 | 27 | Janssen Pharmaceuticals, Inc ($14,980) |
| 2018 | $29,292 | 67 | Janssen Pharmaceuticals, Inc ($24,116) |
| 2017 | $74,380 | 111 | Janssen Pharmaceuticals, Inc ($67,011) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $33.82 | General |
| 09/17/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/28/2024 | Edwards Lifesciences Corporation | HemoSphere (Device) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Hemodynamic Monitoring | ||||||
| 07/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $19.38 | General |
| 06/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $163.39 | General |
| 06/13/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $54.65 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/30/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/10/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/29/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $34.78 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/17/2023 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $42.70 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/18/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.50 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/11/2023 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $93.82 | General |
| Category: Coronary | ||||||
| 10/04/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $131.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $121.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/02/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $104.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/25/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/27/2023 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Vascular | ||||||
| 05/24/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/05/2023 | Acist Medical Systems, Inc. | CVI Systems (Device) | Food and Beverage | In-kind items and services | $43.27 | General |
| Category: Diagnostic Imaging | ||||||
| 04/26/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,012 | 7,272 | $885,502 | $247,754 |
| 2022 | 25 | 2,818 | 8,012 | $862,838 | $258,573 |
| 2021 | 25 | 2,970 | 7,634 | $870,610 | $278,130 |
| 2020 | 29 | 2,867 | 3,858 | $610,088 | $188,443 |
Total Patients
11,667
Total Services
26,776
Medicare Billing
$972,900
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 553 | 856 | $201,160 | $81,259 | 40.4% |
| 93656 | Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | Facility | 2023 | 29 | 30 | $98,100 | $23,418 | 23.9% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 245 | 2,533 | $88,842 | $22,301 | 25.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 193 | 623 | $66,955 | $14,679 | 21.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 641 | 1,019 | $66,235 | $11,269 | 17.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 108 | 108 | $32,770 | $10,832 | 33.1% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 87 | 301 | $55,685 | $8,634 | 15.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 50 | 396 | $33,660 | $8,200 | 24.4% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 17 | 17 | $26,350 | $7,002 | 26.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 77 | 99 | $14,910 | $6,293 | 42.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $17,890 | $5,964 | 33.3% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 55 | 68 | $31,620 | $5,958 | 18.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 43 | 57 | $12,160 | $5,219 | 42.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 619 | 849 | $25,470 | $5,211 | 20.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 28 | 28 | $13,005 | $4,954 | 38.1% |
| 93655 | Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | Facility | 2023 | 18 | 19 | $23,150 | $4,833 | 20.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 34 | 35 | $11,500 | $4,701 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 69 | $10,695 | $4,616 | 43.2% |
| 93657 | Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | Facility | 2023 | 16 | 17 | $18,320 | $4,324 | 23.6% |
| 33228 | Removal and replacement of dual lead permanent pacemaker | Facility | 2023 | 12 | 12 | $12,600 | $3,064 | 24.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $7,055 | $2,417 | 34.3% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 20 | 20 | $4,225 | $1,368 | 32.4% |
| 33285 | Insertion of heart rhythm monitor under skin | Facility | 2023 | 15 | 15 | $12,375 | $1,092 | 8.8% |
| 85610 | Blood test, clotting time | Office | 2023 | 22 | 35 | $770.00 | $147.00 | 19.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 491 | 731 | $171,785 | $71,450 | 41.6% |
About Dr. Steven Rothman, MD
Dr. Steven Rothman, MD is a Clinical Cardiac Electrophysiology healthcare provider based in Wynnewood, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1477559698.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Rothman, MD has received a total of $123,681 in payments from pharmaceutical and medical device companies, with $412.13 received in 2024. These payments were reported across 259 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($97,440).
As a Medicare-enrolled provider, Rothman has provided services to 11,667 Medicare beneficiaries, totaling 26,776 services with total Medicare billing of $972,900. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Cardiac Electrophysiology
- Other Specialties Cardiovascular Disease
- Location Wynnewood, PA
- Active Since 06/22/2005
- Last Updated 06/17/2016
- Taxonomy Code 207RC0001X
- Entity Type Individual
- NPI Number 1477559698
Products in Payments
- XARELTO (Drug) $109,256
- Cardiac Mapping System (Device) $8,995
- Ensite Cardiac Mapping System (Device) $3,360
- ENTRESTO (Drug) $198.67
- WATCHMAN FLX (Device) $158.91
- ELIQUIS (Drug) $138.52
- VYNDAQEL (Drug) $123.82
- FFRct (Device) $93.82
- Assurity Pacemaker (Device) $81.15
- BRILINTA (Drug) $73.91
- LifeVest (Device) $70.63
- Pacemakers (Device) $68.26
- Micra (Device) $61.38
- Ablation Therapy Hardware (Device) $60.79
- WATCHMAN Access System (Device) $49.30
- ATRICURE ATRICLIP LAA EXCLUSION SYSTEM (Device) $47.93
- CVI Systems (Device) $43.27
- ViewMate Intracardiac Echo (Device) $43.06
- FARXIGA (Drug) $41.27
- Confirm Rx (Device) $40.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Cardiac Electrophysiology Doctors in Wynnewood
Peter Kowey, Md, MD
Clinical Cardiac Electrophysiology — Payments: $2.2M
Clinical Cardiac Electrophysiology $2.2M
Douglas Esberg, Md, MD
Clinical Cardiac Electrophysiology — Payments: $79,456
Clinical Cardiac Electrophysiology $79,456
Ali Keramati, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $67,736
Clinical Cardiac Electrophysiology $67,736
Kar Lai Wong, M.d, M.D
Clinical Cardiac Electrophysiology — Payments: $8,991
Clinical Cardiac Electrophysiology $8,991
Gan Xin Yan, Md, MD
Clinical Cardiac Electrophysiology — Payments: $7,444
Clinical Cardiac Electrophysiology $7,444
Maribel Hernandez, Md, MD
Clinical Cardiac Electrophysiology — Payments: $6,571
Clinical Cardiac Electrophysiology $6,571